A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
A Mirabile, C Bergamini, P Bossi, E Civelli, C Morosi, S Lo Vullo, M Imbimbo, P Quattrone, G P Dagrada, R Granata, C Resteghini, S Alfieri, E Orlandi, L Mariani, G Saibene, S Pilotti, L Licitra, F Perrone, B Cortelazzi, L D Locati
European journal of cancer (Oxford, England : 1990) 2017;69():158-165